Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Rowley

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Blood|March 15, 1990
Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trialJ E Wagner, G W Santos, S J Noga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's diseaseR J Jones, S Piantadosi, R B Mann, et al.
Blood|September 25, 1999
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipientsP J Martin, S D Rowley, C Anasetti, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantationM E Flowers, W Leisenring, K Beach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical OncologyC A Schiffer, K C Anderson, C L Bennett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Bone Marrow Transplantation|July 19, 2016
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantationJ Magenau, P Westervelt, S Khaled, et al.
Leukemia|October 19, 2011
Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severityL Grkovic, K Baird, S M Steinberg, et al.
Bone Marrow Transplantation|July 1, 1996
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Blood|March 15, 1990
Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trialJ E Wagner, G W Santos, S J Noga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's diseaseR J Jones, S Piantadosi, R B Mann, et al.
Blood|September 25, 1999
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipientsP J Martin, S D Rowley, C Anasetti, et al.
Blood|January 7, 1998
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host diseaseJ Storek, T Gooley, M Siadak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantationM E Flowers, W Leisenring, K Beach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical OncologyC A Schiffer, K C Anderson, C L Bennett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myelomaW I Bensinger, S D Rowley, T Demirer, et al.
Bone Marrow Transplantation|July 19, 2016
A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantationJ Magenau, P Westervelt, S Khaled, et al.
Leukemia|October 19, 2011
Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severityL Grkovic, K Baird, S M Steinberg, et al.
Bone Marrow Transplantation|July 1, 1996
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cellsM W Brunvand, W I Bensinger, E Soll, et al.
Pageof 7